Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 10015-10023
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Table 1 Demographic characteristics of all 53 patients
Characteristic | Value |
Sex, No. | male/female: 26/27 |
Age, median (range), yr | 63.0 (31-83) |
Tumor location, No. | Esophagus/stomach/duodenum: 4/47/2 |
Table 2 Histopathological diagnosis
Esophagus (n = 4) | Stomach (n = 47) | Duodenum (n = 2) | Total(n = 53) | |
GIMT | 4 | 45 | 0 | 49 |
GIST | 0 | 34 | 0 | 34 |
Leiomyoma | 2 | 3 | 0 | 5 |
Schwannoma | 1 | 2 | 0 | 3 |
Spindle-cell tumor | 1 | 6 | 0 | 7 |
Ectopic pancreas | 0 | 1 | 0 | 1 |
Hamartoma | 0 | 0 | 1 | 1 |
Intramural developmental cyst | 0 | 1 | 0 | 1 |
Brunner’s adenoma | 0 | 0 | 1 | 1 |
Table 3 Details of 53 patients
Resected tumors(n = 34) | Unresected tumors (n = 19) | Total (n = 53) | GIST (n = 34) | |
Follow-up period, median (range), mo | 24.9 (6.6-210) | 36.5 (11.2-183.6) | 31.7 (6.6-210) | 27.3 (6.6-210) |
EUS sessions, median (range) | 3 (2-8) | 4 (2-13) | 3 (2-13) | 3 (2-11) |
Tumor diameter at initial EUS, median (range), mm | 19.5 (10-30) | 19.0 (11.5-44.8) | 19.1 (10-44.8) | 19.0 (10.9-44.8) |
Tumor diameter before surgery or FNA, median (range), mm | 28.0 (20-43.1) | 22.8 (15.2-52.1) | 25.3 (13.7-52.1) | 26.7 (13.7-52.1) |
Time from the final EUS to surgery, median (range) | 3.8 mo (22d-16.3 mo) | - | - | - |
Table 4 Details of 34 patients with gastrointestinal submucosal tumors
Extremely low plus low risk (n = 28) | Intermediate risk(n = 3) | High risk (n = 3) | Total (n = 34) | |
Follow-up period, median (range), mo | 31.0 (6.6-210) | 47.3 (11.2-49.9) | 12.4 (7.4-16.7) | 27.3 (6.6-210) |
Initial tumor diameter, median (range), mm | 18.6 (10.9-30.0) | 28.5 (20.0-44.8) | 25.5 (14.0-27.3) | 19.0 (10.9-44.8) |
Doubling time, median (range), mo | 24.0 (2.0-183.6) | 17.1 (6.1-19.4) | 3.9 (0.8-10.4) | 17.2 (0.8-183.6) |
Table 5 Tumors other than gastrointestinal submucosal tumors
No. of patient | Follow-up period, median (range), mo | Doubling time, median (range), mo | |
Leiomyoma | 5 | 47.1 (10.7-137.2) | 231.2 (21.3-1303.8) |
Schwannoma | 3 | 50.1 (24.3-71.7) | 104.7 (3.9-305.4) |
Ectopic pancreas | 1 | 66.5 | 274.9 |
Hamartoma | 1 | 99.6 | 61.2 |
Intramural developmental cyst | 1 | 29.5 | 49.0 |
Brunner’s adenoma | 1 | 30.6 | 134.7 |
Table 6 Comparison according to diagnosis
Doubling time (mo), median | P value | |
GIST vs Leiomyoma + schwannoma | 17.2 vs 204.2 | 0.005 |
High risk vs Intermediate risk | 3.9 vs 17.1 | 0.127 |
Intermediate risk vs Extremely low + low risk | 17.1 vs 24.0 | 0.423 |
High risk vs Extremely low + low risk | 3.9 vs 24.0 | 0.033 |
High + intermediate risk vs Extremely low + low risk | 8.2 vs 24.0 | 0.047 |
- Citation: Koizumi S, Kida M, Yamauchi H, Okuwaki K, Iwai T, Miyazawa S, Takezawa M, Imaizumi H, Koizumi W. Clinical implications of doubling time of gastrointestinal submucosal tumors. World J Gastroenterol 2016; 22(45): 10015-10023
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/10015.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.10015